Evidence map›Paper›PMID 31652842›Full record

ReviewMetabolites2019

Using Cerebral Metabolites to Guide Precision Medicine for Subarachnoid Hemorrhage: Lactate and Pyruvate.

Kaneez Zahra, Neethu Gopal, William D Freeman, Marion T Turnbull

Open access · goldAbstract readReview
In one paragraph

Review in Metabolites, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kaneez ZahraDepartment of Neurology, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224, USA. zahra.kaneez@mayo.edu.
Neethu GopalDepartment of Neurology, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224, USA. gopal.neethu@mayo.edu.
William D FreemanDepartment of Neurology, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224, USA. freeman.william1@mayo.edu.
Marion T TurnbullDepartment of Neurology, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224, USA. turnbull.marion@mayo.edu.ORCID 0000-0003-4448-5591
Mayo Clinic in Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Subarachnoid hemorrhage (SAH) is one of the deadliest types of strokes with high rates of morbidity and permanent injury. Fluctuations in the levels of cerebral metabolites following SAH can be indicators of brain injury severity. Specifically, the changes in the levels of key metabolites involved in cellular metabolism, lactate and pyruvate, can be used as a biomarker for patient prognosis and tailor treatment to an individual's needs. Here, clinical research is reviewed on the usefulness of cerebral lactate and pyruvate measurements as a predictive tool for SAH outcomes and their potential to guide a precision medicine approach to treatment.

Indexed as

cerebral metabolismdelayed cerebral ischemialactatelactate-pyruvate ratioprecision medicinepyruvatesubarachnoid hemorrhagevasospasm

Identifiers

PMID31652842
PMCPMC6918279
OpenAlexW2982041701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.